Brewer Joanna Elizabeth has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 1612032 shares of Adaptimmune Therapeutics PLC ($ADAPY) on February 20, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Brewer Joanna Elizabeth | Chief Scientific Officer | A | Option to purchase Ordinary Shares | 1612032 | $0.00 | 1,612,032.0000 | 1,513,810,852 | 9999.99% | 0.11% |
| Feb. 20, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Brewer Joanna Elizabeth | Chief Scientific Officer | A | Option to purchase Ordinary Shares | 1074696 | $0.00 | 1,074,696.0000 | 1,513,810,852 | 9999.99% | 0.07% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Brewer Joanna Elizabeth | Chief Scientific Officer | A | Option to purchase Ordinary Shares | 2544432 | $0.00 | 2,544,432.0000 | 1,206,440,978 | 9999.99% | 0.21% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Brewer Joanna Elizabeth | Chief Scientific Officer | A | Option to purchase Ordinary Shares | 565416 | $0.00 | 565,416.0000 | 1,206,440,978 | 9999.99% | 0.05% |